Single-nucleotide-polymorphism genotyping of Coxiella burnetii during a Q fever outbreak in The Netherlands.
Coxiella burnetii is the etiological agent of Q fever. Currently, the Netherlands is facing the largest Q fever epidemic ever, with almost 4,000 notified human cases. Although the presence of a hypervirulent strain is hypothesized, epidemiological evidence, such as the animal reservoir(s) and genotype of the C. burnetii strain(s) involved, is still lacking. We developed a single-nucleotide-polymorphism (SNP) genotyping assay directly applicable to clinical samples. Ten discriminatory SNPs were carefully selected and detected by real-time PCR. SNP genotyping appeared to be highly suitable for discrimination of C. burnetii strains and easy to perform with clinical samples. With this new method, we show that the Dutch outbreak is caused by at least 5 different C. burnetii genotypes. SNP typing of 14 human samples from the outbreak revealed the presence of 3 dissimilar genotypes. Two genotypes were also present in livestock at 9 farms in the outbreak area. SNP analyses of bulk milk from 5 other farms, commercial cow milk, and cow colostrum revealed 2 additional genotypes that were not detected in humans. SNP genotyping data from clinical samples clearly demonstrate that at least 5 different C. burnetii genotypes are involved in the Dutch outbreak.
Laboratory of Molecular Diagnostics, Jeroen Bosch Hospital, Nieuwstraat 34, 5211 NL 's-Hertogenbosch, Netherlands. r.huysmans@jbz.nl
Cornelis J J
CJ
Huijsmans
Jeroen J A
JJ
Schellekens
Peter C
PC
Wever
Rudolf
R
Toman
Paul H M
PH
Savelkoul
Ingmar
I
Janse
Mirjam H A
MH
Hermans
D016997:Coxiella burnetii / Q000145:classification / Q000235:genetics* / Q000472:pathogenicity*; D005838:Genotype; D006801:Humans; D009426:Netherlands / Q000453:epidemiology; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D011778:Q Fever / Q000453:epidemiology* / Q000382:microbiology*
J Clin Microbiol. 2010 Nov;48(11):3923-7
20826645
Am J Trop Med Hyg. 1961 Jan;10:49-52
13735474
FEMS Microbiol Lett. 1999 Nov 15;180(2):249-54
10556719
Euro Surveill. 2010 Mar 25;15(12):
20350500
J Gen Microbiol. 1991 Feb;137(2):269-76
1673152
FEMS Immunol Med Microbiol. 2007 Feb;49(1):22-7
17266711
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5455-60
12704232
J Mol Diagn. 2007 Apr;9(2):205-13
17384212
Vet Microbiol. 2010 May 19;142(3-4):450-4
19931322
BMC Microbiol. 2008 Jun 02;8:86
18518958
J Clin Microbiol. 1998 Aug;36(8):2210-3
9665993
Eur J Epidemiol. 1993 Jul;9(4):419-25
7902294
Ann N Y Acad Sci. 2006 Oct;1078:563-5
17114778
FEMS Microbiol Lett. 2006 Jan;254(2):268-74
16445755
Science. 2010 Jan 15;327(5963):266-7
20075230
J Clin Microbiol. 2006 Feb;44(2):374-7
16455886
Curr Opin Genet Dev. 2005 Dec;15(6):572-83
16230003
Lancet Infect Dis. 2005 Apr;5(4):219-26
15792739
Trans Assoc Am Physicians. 1956;69:98-104
13380951
J Clin Microbiol. 2010 Apr;48(4):1461-4
20181906
Emerg Infect Dis. 2009 Apr;15(4):613-4
19331749
Ann N Y Acad Sci. 2005 Dec;1063:105-14
16481501
Euro Surveill. 2009 May 14;14(19):
19442401
Anal Chem. 2008 Sep 15;80(18):7097-104
18707130
Lancet Infect Dis. 2003 Nov;3(11):709-21
14592601
Emerg Infect Dis. 2005 Aug;11(8):1211-7
16102309
BMC Microbiol. 2006 Apr 26;6:38
16640773